The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Value Trend Is Expected For The Intranasal Drug Delivery Devices Market From 2026 To 2030?
The intranasal drug delivery devices market has shown robust growth over recent years. It is anticipated to increase from $65.09 billion in 2025 to $70.77 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. The expansion observed in the past can be attributed to several factors, including the rising prevalence of respiratory and nasal ailments, the increasing utilization of the nasal route for systemic drug delivery, the development of self-administration drug devices, a greater number of approvals for intranasal therapies, and the broadening of outpatient treatment approaches.
The intranasal drug delivery devices market is projected to experience robust expansion in the coming years, set to reach $99.11 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8%. This anticipated growth during the forecast period is primarily driven by factors such as the increasing creation of biologics and vaccines for nasal administration, a surging need for drug delivery in homecare settings, the broadening application of intranasal delivery for neurological treatments, increasing financial commitments towards sophisticated drug-device combinations, and a heightened emphasis on solutions that improve patient adherence. Key trends expected throughout this period encompass the growing integration of precision nasal delivery systems, an escalating preference for non-invasive methods of drug administration, the continued evolution of multi-dose nasal devices, a wider array of patient-convenient drug delivery formats, and an intensified focus on achieving quick drug absorption.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp
Which Core Factors Are Supporting The Expansion Of The Intranasal Drug Delivery Devices Market?
The rising prevalence of chronic diseases is projected to stimulate the growth of the intranasal drug delivery devices market in the future. Chronic diseases are defined as conditions that persist for 1 year or more, necessitating ongoing medical attention, limiting daily living activities, or both. Intranasal drug delivery devices are utilized to manage these conditions by offering a non-invasive and effective means of administering medications. They enable direct drug delivery to the affected area, which is convenient, easy to use, and facilitates rapid absorption. For example, in June 2024, the National Health Service, a UK-based government department, reported that in 2023, the count of individuals in England at risk of developing type 2 diabetes climbed to 3,615,330, an increase from 3,066,330 in 2022, with an additional 549,000 people identified with non-diabetic hyperglycemia, or pre-diabetes. Consequently, the increasing prevalence of chronic diseases is a primary driver for the expansion of the intranasal drug delivery devices market.
Which Segment-Based Categories Are Covered In The Intranasal Drug Delivery Devices Market?
The intranasal drug delivery devices market covered in this report is segmented –
1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products
2) By Dosage: Unit-Dose, Multi-Dose
3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications
4) By End User: Hospitals, Clinics, Homecare, Other End Users
Subsegments:
1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device
2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device
3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs
4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays
Which Trends Are Contributing To Changes In The Intranasal Drug Delivery Devices Market?
Major companies active in the intranasal drug delivery devices market are prioritizing the development of improved products, such as recyclable polyolefin nasal spray actuators, to boost sustainability, enhance patient compliance, and facilitate environmentally friendly drug delivery solutions. A recyclable polyolefin nasal spray actuator is a nasal drug delivery component constructed entirely from polyolefin materials, designed for multiple-dose administration without any metal parts. For example, in January 2023, Aptar Pharma, a US-based drug delivery and pharmaceutical solutions company, introduced the APF Futurity, which is the first metal-free multidose nasal spray pump created to address the increasing demand for highly recyclable packaging. The APF Futurity is made entirely from polyolefin materials, contains no metal components, and possesses a Class AA highly recyclable certification from cyclos-HTP. This pump offers precise and consistent dosing with gentle actuation, is compatible with nasal saline and other over-the-counter formulations, and supports sustainable recycling, thereby making it an ideal option for environmentally conscious drug delivery solutions and patient convenience.
Who Are The Companies Shaping The Intranasal Drug Delivery Devices Market Landscape?
Major companies operating in the intranasal drug delivery devices market are Johnson and Johnson Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, 3M Company, Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group plc., OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, ENT Technologies Pty. Ltd., Neurelis Inc.
Access The Complete Intranasal Drug Delivery Devices Market Report:
Which Region Stands As The Largest Contributor To The Intranasal Drug Delivery Devices Market?
North America was the largest region in the intranasal drug delivery devices market in 2025. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Intranasal Drug Delivery Devices Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Intranasal Drug Delivery Devices Market 2026, By The Business Research Company
Nail Salon Market Report 2026
https://www.thebusinessresearchcompany.com/report/nail-salon-global-market-report
Nail Polish Market Report 2026
https://www.thebusinessresearchcompany.com/report/nail-polish-global-market-report
Medical Tubing Market Report 2026
https://www.thebusinessresearchcompany.com/report/medical-tubing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model